Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noritaka Ohga

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Pathology|December 16, 2014
Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxelKosuke Akiyama, Nako Maishi, Noritaka Ohga, et al.
International Journal of Cancer|June 24, 2015
CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic propertyKenji Yamada, Nako Maishi, Kosuke Akiyama, et al.
Biochemical and Biophysical Research Communications|March 23, 2010
Isolated tumor endothelial cells maintain specific character during long-term cultureKohei Matsuda, Noritaka Ohga, Yasuhiro Hida, et al.
Journal of Medical Case Reports|April 3, 2024
Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literatureKen-Ichiro Sakata, Ayako Hashimoto, Taiho Kambe, et al.
Anticancer Research|March 19, 2017
Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell CarcinomaChisaho Torii, Yasuhiro Hida, Masanobu Shindoh, et al.
The American Journal of Pathology|January 17, 2012
Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironmentKosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, et al.
Pathology International|November 19, 2016
Tumor endothelial cells express high pentraxin 3 levelsKyoko Hida, Nako Maishi, Taisuke Kawamoto, et al.
Cancer Science|March 8, 2014
Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cellsTsuguteru Otsubo, Yasuhiro Hida, Noritaka Ohga, et al.
Cancer Science|August 30, 2017
Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistanceKyoko Hida, Nako Maishi, Kosuke Akiyama, et al.
Oncology Letters|November 20, 2024
Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case reportTaku Kimura, Ken-Ichiro Sakata, Noritaka Ohga, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Pathology|December 16, 2014
Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxelKosuke Akiyama, Nako Maishi, Noritaka Ohga, et al.
International Journal of Cancer|June 24, 2015
CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic propertyKenji Yamada, Nako Maishi, Kosuke Akiyama, et al.
Biochemical and Biophysical Research Communications|March 23, 2010
Isolated tumor endothelial cells maintain specific character during long-term cultureKohei Matsuda, Noritaka Ohga, Yasuhiro Hida, et al.
Journal of Medical Case Reports|April 3, 2024
Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: two case reports and a review of the literatureKen-Ichiro Sakata, Ayako Hashimoto, Taiho Kambe, et al.
Anticancer Research|March 19, 2017
Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell CarcinomaChisaho Torii, Yasuhiro Hida, Masanobu Shindoh, et al.
The American Journal of Pathology|January 17, 2012
Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironmentKosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, et al.
Pathology International|November 19, 2016
Tumor endothelial cells express high pentraxin 3 levelsKyoko Hida, Nako Maishi, Taisuke Kawamoto, et al.
Cancer Science|March 8, 2014
Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cellsTsuguteru Otsubo, Yasuhiro Hida, Noritaka Ohga, et al.
Cancer Science|August 30, 2017
Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistanceKyoko Hida, Nako Maishi, Kosuke Akiyama, et al.
Oncology Letters|November 20, 2024
Salivary miRNAs as a novel therapeutic marker in a patient with advanced oral squamous cell carcinoma: A case reportTaku Kimura, Ken-Ichiro Sakata, Noritaka Ohga, et al.
Pageof 7